VT
Vijay Thiruvenkatam
About Vijay Thiruvenkatam
Data last updated:
Vijay Thiruvenkatam is a Director at Procyl Therapeutics Private Limited (since 2023). The company operates in Software. Procyl Therapeutics Private Limited reported revenue of ₹25,000 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Procyl Therapeutics Private Limited U72200GJ2023PTC139287 | Director | 17 Mar 2023 | 2023 | ₹25,000 (FY 2025) | Active |
Board colleagues of Vijay Thiruvenkatam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dharmeshkumar Amratlal Patel | 08737495 | Procyl Therapeutics Private Limited | Director |
| Ripal Rasiklal Khamar | 09594788 | Procyl Therapeutics Private Limited | Director |
| Sivapriya Kirubakaran | 10077533 | Procyl Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Thiruvenkatam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Thiruvenkatam
Vijay Thiruvenkatam currently holds 1 directorship: Procyl Therapeutics Private Limited (Director, since 17 Mar 2023, revenue ₹25,000 (FY 2025)).
Vijay Thiruvenkatam was first appointed on 17 Mar 2023 as Director at Procyl Therapeutics Private Limited.
The current boards of Vijay Thiruvenkatam's companies include Dharmeshkumar Amratlal Patel (Procyl Therapeutics Private Limited), Ripal Rasiklal Khamar (Procyl Therapeutics Private Limited), Sivapriya Kirubakaran (Procyl Therapeutics Private Limited).